Report cover image

Streptococcus Pneumoniae Polysaccharide Vaccine Industry Research Report 2025

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 126 Pages
SKU # APRC20351984

Description

Summary

According to APO Research, the global Streptococcus Pneumoniae Polysaccharide Vaccine market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Streptococcus Pneumoniae Polysaccharide Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Streptococcus Pneumoniae Polysaccharide Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Streptococcus Pneumoniae Polysaccharide Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Streptococcus Pneumoniae Polysaccharide Vaccine include Yuxi Watson Biotechnology Co., Ltd, Merck & Co.,Inc, Pfizer Inc, Chengdu Institute of Biological Products Co., Ltd, Beijing Minhai Biotechnology Co., Ltd, Beijing Kexing Biological Products Co., Ltd, Serum Institute of India Pvt. Ltd, Sanofi Pasteur and Glaxosmithkline Plc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Streptococcus Pneumoniae Polysaccharide Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Streptococcus Pneumoniae Polysaccharide Vaccine.

The report will help the Streptococcus Pneumoniae Polysaccharide Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Streptococcus Pneumoniae Polysaccharide Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Streptococcus Pneumoniae Polysaccharide Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Streptococcus Pneumoniae Polysaccharide Vaccine Segment by Company

Yuxi Watson Biotechnology Co., Ltd
Merck & Co.,Inc
Pfizer Inc
Chengdu Institute of Biological Products Co., Ltd
Beijing Minhai Biotechnology Co., Ltd
Beijing Kexing Biological Products Co., Ltd
Serum Institute of India Pvt. Ltd
Sanofi Pasteur
Glaxosmithkline Plc
China National Biotec Group
Astellas Pharma Inc
Streptococcus Pneumoniae Polysaccharide Vaccine Segment by Type

Single Dose Vial
Pre-Filled Syringe
Streptococcus Pneumoniae Polysaccharide Vaccine Segment by Application

Hospital
Clinic
Streptococcus Pneumoniae Polysaccharide Vaccine Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Streptococcus Pneumoniae Polysaccharide Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Streptococcus Pneumoniae Polysaccharide Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Streptococcus Pneumoniae Polysaccharide Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Streptococcus Pneumoniae Polysaccharide Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Streptococcus Pneumoniae Polysaccharide Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Streptococcus Pneumoniae Polysaccharide Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Table of Contents

126 Pages
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Size (2020-2031)
2.2.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales (2020-2031)
2.2.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Average Price (2020-2031)
2.3 Streptococcus Pneumoniae Polysaccharide Vaccine by Type
2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
2.3.2 Single Dose Vial
2.3.3 Pre-Filled Syringe
2.4 Streptococcus Pneumoniae Polysaccharide Vaccine by Application
2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.4.2 Hospital
2.4.3 Clinic
3 Market Competitive Landscape by Manufacturers
3.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Competitive Situation by Manufacturers (2020 Versus 2024)
3.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units) of Manufacturers (2020-2025)
3.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue of Manufacturers (2020-2025)
3.4 Global Streptococcus Pneumoniae Polysaccharide Vaccine Average Price by Manufacturers (2020-2025)
3.5 Global Streptococcus Pneumoniae Polysaccharide Vaccine Industry Ranking, 2023 VS 2024 VS 2025
3.6 Global Manufacturers of Streptococcus Pneumoniae Polysaccharide Vaccine, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Streptococcus Pneumoniae Polysaccharide Vaccine, Product Type & Application
3.8 Global Manufacturers of Streptococcus Pneumoniae Polysaccharide Vaccine, Established Date
3.9 Global Streptococcus Pneumoniae Polysaccharide Vaccine Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Yuxi Watson Biotechnology Co., Ltd
4.1.1 Yuxi Watson Biotechnology Co., Ltd Company Information
4.1.2 Yuxi Watson Biotechnology Co., Ltd Business Overview
4.1.3 Yuxi Watson Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2020-2025)
4.1.4 Yuxi Watson Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
4.1.5 Yuxi Watson Biotechnology Co., Ltd Recent Developments
4.2 Merck & Co.,Inc
4.2.1 Merck & Co.,Inc Company Information
4.2.2 Merck & Co.,Inc Business Overview
4.2.3 Merck & Co.,Inc Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2020-2025)
4.2.4 Merck & Co.,Inc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
4.2.5 Merck & Co.,Inc Recent Developments
4.3 Pfizer Inc
4.3.1 Pfizer Inc Company Information
4.3.2 Pfizer Inc Business Overview
4.3.3 Pfizer Inc Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2020-2025)
4.3.4 Pfizer Inc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
4.3.5 Pfizer Inc Recent Developments
4.4 Chengdu Institute of Biological Products Co., Ltd
4.4.1 Chengdu Institute of Biological Products Co., Ltd Company Information
4.4.2 Chengdu Institute of Biological Products Co., Ltd Business Overview
4.4.3 Chengdu Institute of Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2020-2025)
4.4.4 Chengdu Institute of Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
4.4.5 Chengdu Institute of Biological Products Co., Ltd Recent Developments
4.5 Beijing Minhai Biotechnology Co., Ltd
4.5.1 Beijing Minhai Biotechnology Co., Ltd Company Information
4.5.2 Beijing Minhai Biotechnology Co., Ltd Business Overview
4.5.3 Beijing Minhai Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2020-2025)
4.5.4 Beijing Minhai Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
4.5.5 Beijing Minhai Biotechnology Co., Ltd Recent Developments
4.6 Beijing Kexing Biological Products Co., Ltd
4.6.1 Beijing Kexing Biological Products Co., Ltd Company Information
4.6.2 Beijing Kexing Biological Products Co., Ltd Business Overview
4.6.3 Beijing Kexing Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2020-2025)
4.6.4 Beijing Kexing Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
4.6.5 Beijing Kexing Biological Products Co., Ltd Recent Developments
4.7 Serum Institute of India Pvt. Ltd
4.7.1 Serum Institute of India Pvt. Ltd Company Information
4.7.2 Serum Institute of India Pvt. Ltd Business Overview
4.7.3 Serum Institute of India Pvt. Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2020-2025)
4.7.4 Serum Institute of India Pvt. Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
4.7.5 Serum Institute of India Pvt. Ltd Recent Developments
4.8 Sanofi Pasteur
4.8.1 Sanofi Pasteur Company Information
4.8.2 Sanofi Pasteur Business Overview
4.8.3 Sanofi Pasteur Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2020-2025)
4.8.4 Sanofi Pasteur Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
4.8.5 Sanofi Pasteur Recent Developments
4.9 Glaxosmithkline Plc
4.9.1 Glaxosmithkline Plc Company Information
4.9.2 Glaxosmithkline Plc Business Overview
4.9.3 Glaxosmithkline Plc Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2020-2025)
4.9.4 Glaxosmithkline Plc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
4.9.5 Glaxosmithkline Plc Recent Developments
4.10 China National Biotec Group
4.10.1 China National Biotec Group Company Information
4.10.2 China National Biotec Group Business Overview
4.10.3 China National Biotec Group Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2020-2025)
4.10.4 China National Biotec Group Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
4.10.5 China National Biotec Group Recent Developments
4.11 Astellas Pharma Inc
4.11.1 Astellas Pharma Inc Company Information
4.11.2 Astellas Pharma Inc Business Overview
4.11.3 Astellas Pharma Inc Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2020-2025)
4.11.4 Astellas Pharma Inc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
4.11.5 Astellas Pharma Inc Recent Developments
5 Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Scenario by Region
5.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Region: 2020 VS 2024 VS 2031
5.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Region: 2020-2031
5.2.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Region: 2020-2025
5.2.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Region: 2026-2031
5.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Region: 2020-2031
5.3.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Region: 2020-2025
5.3.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Region: 2026-2031
5.4 North America Streptococcus Pneumoniae Polysaccharide Vaccine Market Facts & Figures by Country
5.4.1 North America Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Country: 2020 VS 2024 VS 2031
5.4.2 North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2020-2031)
5.4.3 North America Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Country (2020-2031)
5.4.4 United States
5.4.5 Canada
5.5 Europe Streptococcus Pneumoniae Polysaccharide Vaccine Market Facts & Figures by Country
5.5.1 Europe Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Country: 2020 VS 2024 VS 2031
5.5.2 Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2020-2031)
5.5.3 Europe Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Country (2020-2031)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Netherlands
5.6 Asia Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Market Facts & Figures by Country
5.6.1 Asia Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Country: 2020 VS 2024 VS 2031
5.6.2 Asia Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2020-2031)
5.6.3 Asia Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Country (2020-2031)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Southeast Asia
5.7 South America Streptococcus Pneumoniae Polysaccharide Vaccine Market Facts & Figures by Country
5.7.1 South America Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Country: 2020 VS 2024 VS 2031
5.7.2 South America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2020-2031)
5.7.3 South America Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Country (2020-2031)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Market Facts & Figures by Country
5.8.1 Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Country: 2020 VS 2024 VS 2031
5.8.2 Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2020-2031)
5.8.3 Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Country (2020-2031)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2020-2031)
6.1.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2020-2031) & (K Units)
6.1.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Type (2020-2031)
6.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Type (2020-2031)
6.2.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2020-2031) & (US$ Million)
6.2.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Type (2020-2031)
6.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Price by Type (2020-2031)
7 Segment by Application
7.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2020-2031)
7.1.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2020-2031) & (K Units)
7.1.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Application (2020-2031)
7.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Application (2020-2031)
7.2.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2020-2031) & (US$ Million)
7.2.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Application (2020-2031)
7.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Price by Application (2020-2031)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Streptococcus Pneumoniae Polysaccharide Vaccine Value Chain Analysis
8.1.1 Streptococcus Pneumoniae Polysaccharide Vaccine Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Streptococcus Pneumoniae Polysaccharide Vaccine Production Mode & Process
8.2 Streptococcus Pneumoniae Polysaccharide Vaccine Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Streptococcus Pneumoniae Polysaccharide Vaccine Distributors
8.2.3 Streptococcus Pneumoniae Polysaccharide Vaccine Customers
9 Global Streptococcus Pneumoniae Polysaccharide Vaccine Analyzing Market Dynamics
9.1 Streptococcus Pneumoniae Polysaccharide Vaccine Industry Trends
9.2 Streptococcus Pneumoniae Polysaccharide Vaccine Industry Drivers
9.3 Streptococcus Pneumoniae Polysaccharide Vaccine Industry Opportunities and Challenges
9.4 Streptococcus Pneumoniae Polysaccharide Vaccine Industry Restraints
10 Report Conclusion
11 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.